Draft and Revised Draft Guidances for Industry; Availability: Describing Product-Specific Bioequivalence Recommendations
Title: Pfizer Inc Comment
Pfizer Inc. - Comments
This is comment on Notice
Draft and Revised Draft Guidances for Industry; Availability: Describing Product-Specific Bioequivalence Recommendations
View Comment
Attachments:
Pfizer Inc Comment
Title:
Pfizer Inc Comment
Related Comments
Public Submission Posted: 08/07/2012 ID: FDA-2007-D-0369-0090
Aug 13,2012 11:59 PM ET
Public Submission Posted: 01/07/2013 ID: FDA-2007-D-0369-0101
Aug 13,2012 11:59 PM ET